EU AI Act Regulation (EU) 2024/1689, high-risk obligations apply December 2027
Addressed

Articles 9, 13, and 15 require testing for failure modes, robustness across varied inputs, and documented performance limitations. contradish tests 16 phrasing variants per policy area and exports a PDF/JSON report of every failure found.

Executive Order 14110 Signed October 2023, rescinded January 2025
Rescinded

Superseded by EO 14179 and no longer in force. OMB M-25-21 (below) remains the operative federal testing baseline.

OMB Memorandum M-25-21 Issued April 2025, replaces M-24-10
Addressed

Requires pre-deployment testing and ongoing monitoring for high-impact federal AI systems. contradish covers both: a pre-launch phrasing-robustness suite, plus timestamped re-runs after deployment.

FDA AI/ML Guidance AI/ML-based Software as a Medical Device (SaMD)
Addressed

Requires reproducible pre-market validation and post-market drift monitoring. contradish's reports are reproducible and timestamped, exportable for 510(k)/De Novo submissions and re-run to detect drift after updates.

ISO/IEC 42001 AI management system standard, published December 2023
Addressed

Clause 9.1 requires documented, repeatable performance evaluation; Clause 6.1 requires a documented AI risk register. contradish's structured evaluation results and failure inventory feed both directly.

FTC Act, Section 5 Unfair or deceptive acts or practices
Addressed

Safety or policy-adherence claims about an AI product need substantiation. contradish's test evidence is that substantiation.

NAIC AI Model Bulletin Approved December 2023, adopted by 20+ states and DC
Addressed

Insurers are expected to test for errors, drift, and unfair discrimination before deployment and on an ongoing basis, with documented governance. contradish's pre-launch and recurring reports plug directly into that documentation.